International differences in patient access to ultra-orphan drugs
Sign Up to like & getrecommendations! Published in 2017 at "Health policy and technology"
DOI: 10.1016/j.hlpt.2017.12.001
Abstract: Abstract Objectives Reimbursement recommendations on (orphan) drugs are usually made at a national level and this can lead to variation in patient access to the same drug in different countries. We compared differences in patient… read more here.
Keywords: status; orphan; orphan drugs; patient access ... See more keywords